{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T12:43:44Z","timestamp":1715604224654},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/jcn.0b013e318197aa3a","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T03:11:25Z","timestamp":1372907485000},"page":"140-150","source":"Crossref","is-referenced-by-count":6,"title":["Cardiometabolic Risk Among African American Women"],"prefix":"10.1097","volume":"24","author":[{"given":"Susan J.","family":"Appel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Oster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie A.","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Ovalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-11-20210128","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/meta.2003.50057","article-title":"Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, Hispanic, and Asian\/Pacific Islander women.","volume":"52","author":"Howard","year":"2003","journal-title":"Metabolism"},{"key":"R4-11-20210128","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00149831-200410000-00003","article-title":"Major CHD risk factors predominate among African-American women who are eligible for lipid-lowering drug therapy under the new ATP III guidelines.","volume":"11","author":"Koro","year":"2004","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"R5-11-20210128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1532-5415.2001.49030.x","article-title":"Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey.","volume":"49","author":"Sundquist","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"R6-11-20210128","first-page":"S6","article-title":"Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study.","volume":"15","author":"Taylor","year":"2005","journal-title":"Ethn Dis"},{"issue":"8","key":"R7-11-20210128","first-page":"E290","article-title":"Racial differences in PAI-1 levels among healthy African-American and caucasian women.","volume":"115","author":"Appel","year":"2007","journal-title":"Circ Suppl"},{"key":"R8-11-20210128","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.2337\/diabetes.52.8.2168","article-title":"Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin.","volume":"52","author":"Bergman","year":"2003","journal-title":"Diabetes"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00006199-200205000-00002","article-title":"Racial and socioeconomic differences in risk factors for cardiovascular disease among Southern rural women.","volume":"51","author":"Appel","year":"2002","journal-title":"Nurs Res"},{"issue":"5","key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ajcn\/76.5.923","article-title":"Effects of weight loss on changes in insulin sensitivity and lipid concentrations in premenopausal African American and white women.","volume":"76","author":"Gower","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"R13-11-20210128","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/j.amjcard.2005.11.010","article-title":"The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.","volume":"97","author":"Haffner","year":"2006","journal-title":"Am J Cardiol"},{"issue":"2","key":"R14-11-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2005.12.010","article-title":"Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease:a population-based study.","volume":"189","author":"Jeppesen","year":"2006","journal-title":"Atherosclerosis"},{"key":"R15-11-20210128","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/diacare.29.03.06.dc05-1755","article-title":"Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study.","volume":"29","author":"Lorenzo","year":"2006","journal-title":"Diabetes Care"},{"issue":"8","key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1210\/jc.2006-0594","article-title":"Body mass index, metabolic syndrome and risk of type 2 diabetes or cardiovascular disease.","volume":"91","author":"Meigs","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R18-11-20210128","first-page":"95","article-title":"C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.","volume":"42","author":"Apetrei","year":"2004","journal-title":"Rom J Intern Med"},{"key":"R19-11-20210128","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00059-003-2497-5","article-title":"Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?.","volume":"28","author":"Jaeger","year":"2003","journal-title":"Herz"},{"key":"R20-11-20210128","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1161\/01.CIR.94.9.2057","article-title":"Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.","volume":"94","author":"Juhan-Vague","year":"1996","journal-title":"Circulation"},{"issue":"suppl 1","key":"R21-11-20210128","first-page":"78","article-title":"Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.","volume":"32","author":"Juhan-Vague","year":"2000","journal-title":"Ann Med"},{"key":"R22-11-20210128","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0038-1657607","article-title":"PAI-1, obesity, insulin resistance and risk of cardiovascular events.","volume":"78","author":"Juhan-Vague","year":"1997","journal-title":"Thromb Haemost"},{"key":"R23-11-20210128","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/204748739900600602","article-title":"Plasminogen activator inhibitor-1 and carotid intima-media thickening in patients with newly detected primary hypertension.","volume":"6","author":"Marchesi","year":"1999","journal-title":"J Cardiovasc Risk"},{"key":"R24-11-20210128","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.ijo.0803189","article-title":"Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome.","volume":"30","author":"Mertens","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"R25-11-20210128","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.288.8.980","article-title":"Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.","volume":"288","author":"Pradhan","year":"2002","journal-title":"JAMA"},{"issue":"suppl 2","key":"R26-11-20210128","first-page":"22","article-title":"Proceedings of the American College of Endocrinology Insulin Resistance Syndrome Conference. Washington, DC, USA. August 25-26, 2002.","volume":"9","year":"2003","journal-title":"Endocr Pract"},{"key":"R27-11-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5694\/j.1326-5377.2005.tb06987.x","article-title":"Mainstreaming the metabolic syndrome: a definitive definition. This new definition should assist both researchers and clinicians.","volume":"183","author":"Zimmet","year":"2005","journal-title":"Med J Aust"},{"key":"R28-11-20210128","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.2337\/dc07-S093","article-title":"Position statement: screening.","volume":"30","year":"2007","journal-title":"Diabetes Care"},{"key":"R29-11-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5551\/jat.12.295","article-title":"The metabolic syndrome: a global public health problem and a new definition.","volume":"12","author":"Zimmet","year":"2005","journal-title":"J Atheroscler Thromb"},{"key":"R30-11-20210128","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"R31-11-20210128","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2337\/diacare.28.11.2745","article-title":"Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"key":"R32-11-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1745-7599.2005.0052.x","article-title":"Calculating insulin resistance in the primary care setting: why should we worry about insulin levels in euglycemic patients?","volume":"17","author":"Appel","year":"2005","journal-title":"J Am Acad Nurse Pract"},{"key":"R33-11-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","article-title":"Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.","volume":"23","author":"Bonora","year":"2000","journal-title":"Diabetes Care"},{"key":"R34-11-20210128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R35-11-20210128","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/diacare.22.10.1655","article-title":"A quantitative scale of acanthosis nigricans.","volume":"22","author":"Burke","year":"1999","journal-title":"Diabetes Care"},{"key":"R36-11-20210128","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S1047-2797(03)00053-X","article-title":"Relationship of total and abdominal adiposity with CRP and IL-6 in women.","volume":"13","author":"Rexrode","year":"2003","journal-title":"Ann Epidemiol"},{"key":"R37-11-20210128","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/01.CIR.0000132467.45278.59","article-title":"Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"R38-11-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-145-1-200607040-00128","article-title":"The effect of including C-reactive protein in cardiovascular risk prediction models for women.","volume":"145","author":"Cook","year":"2006","journal-title":"Ann Intern Med"},{"key":"R39-11-20210128","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1538-7836.2005.01277.x","article-title":"Hemostatic abnormalities associated with obesity and the metabolic syndrome.","volume":"3","author":"Reaven","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R40-11-20210128","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00006199-200509000-00008","article-title":"African American women, metabolic syndrome, and National Cholesterol Education Program criteria: a pilot study.","volume":"54","author":"Appel","year":"2005","journal-title":"Nurs Res"},{"key":"R41-11-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1745-7599.2006.00127.x","article-title":"Metabolic syndrome: fact or fiction.","volume":"18","author":"Appel","year":"2006","journal-title":"J Am Acad Nurse Pract"},{"key":"R42-11-20210128","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2337\/diacare.27.4.978","article-title":"Critical evaluation of Adult Treatment Panel III criteria in identifying insulin resistance with dyslipidemia.","volume":"27","author":"Liao","year":"2004","journal-title":"Diabetes Care"},{"issue":"3","key":"R43-11-20210128","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events.","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"R44-11-20210128","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/01.CIR.0000132467.45278.59","article-title":"Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"key":"R45-11-20210128","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/01.ATV.0000189155.75833.c7","article-title":"Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute.","volume":"25","author":"Grundy","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R46-11-20210128","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"key":"R47-11-20210128","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2337\/diabetes.53.5.1195","article-title":"Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome.","volume":"53","author":"Cheal","year":"2004","journal-title":"Diabetes"},{"key":"R48-11-20210128","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ecl.2004.03.002","article-title":"The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals.","volume":"33","author":"Reaven","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R49-11-20210128","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/jama.285.16.2109","article-title":"Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study.","volume":"285","author":"de Vegt","year":"2001","journal-title":"JAMA"},{"key":"R50-11-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"R51-11-20210128","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"R52-11-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ecl.2003.12.006","article-title":"Prediabetes: prediction and prevention trials.","volume":"33","author":"Vendrame","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R54-11-20210128","first-page":"67","article-title":"Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies.","volume":"117","author":"Macy","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"R56-11-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.06.027","article-title":"Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study.","volume":"1109","author":"Santaguida","year":"2006","journal-title":"Brain Res"},{"key":"R57-11-20210128","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR).","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet Med"},{"key":"R58-11-20210128","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0300-8932(05)74065-3","article-title":"A new International Diabetes Federation worldwide definition of the metabolic syndrome: the rationale and the results.","volume":"58","author":"Zimmet","year":"2005","journal-title":"Rev Esp Cardiol"},{"key":"R59-11-20210128","first-page":"vii","article-title":"Metabolic syndrome: broadening the understanding of African-American women's risk for cardiovascular disease.","volume":"15","author":"Appel","year":"2004","journal-title":"J Natl Black Nurses Assoc"},{"key":"R60-11-20210128","first-page":"47","article-title":"An overview and update on the metabolic syndrome: implications for identifying cardiometabolic risk among African-American women.","volume":"17","author":"Appel","year":"2006","journal-title":"J Natl Black Nurses Assoc"},{"key":"R61-11-20210128","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1161\/01.ATV.19.9.2234","article-title":"LDL size in African Americans, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study.","volume":"19","author":"Haffner","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R62-11-20210128","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0895-4356(92)90152-D","article-title":"A comparison of the effects of cholesterol on CHD mortality in black and white women: twenty-eight years of follow-up in the Charleston Heart Study.","volume":"45","author":"Knapp","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R63-11-20210128","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/oxfordjournals.aje.a009696","article-title":"African American-white differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study.","volume":"148","author":"Metcalf","year":"1998","journal-title":"Am J Epidemiol"},{"key":"R65-11-20210128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00019501-200502000-00007","article-title":"High prevalence of metabolic syndrome among young women with premature coronary artery disease.","volume":"16","author":"Turhan","year":"2005","journal-title":"Coron Artery Dis"}],"container-title":["Journal of Cardiovascular Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCN.0b013e318197aa3a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:42:38Z","timestamp":1620956558000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005082-200903000-00011"}},"subtitle":["A Pilot Study"],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/jcn.0b013e318197aa3a","relation":{},"ISSN":["0889-4655"],"issn-type":[{"value":"0889-4655","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}